The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care
Open accessAbstract
BACKGROUND: In patients with diabetes, hospitalization can complicate the achievement of recommended glycemic targets. There is increasing evidence that a closed-loop delivery system (artificial pancreas) can improve glucose control in patients with type 1 diabetes. We wanted to investigate whether a closed-loop system could also improve glycemic control in patients with type 2 diabetes who were receiving noncritical care. METHODS: In this randomized, open-label trial conducted on general wards in two tertiary hospitals located in the United Kingdom and Switzerland, we assigned 136 adults with type 2 diabetes who required subcutaneous insulin therapy to receive either closed-loop insulin delivery (70 patients) or conventional subcutaneous insulin therapy, according to local clinical practice (66 patients). The primary end point was the percentage of time that the sensor glucose measurement was within the target range of 100 to 180 mg per deciliter (5.6 to 10.0 mmol per liter) for up to 15 days or until hospital discharge. RESULTS: The mean (±SD) percentage of time that the sensor glucose measurement was in the target range was 65.8±16.8% in the closed-loop group and 41.5±16.9% in the control group, a difference of 24.3±2.9 percentage points (95% confidence interval [CI], 18.6 to 30.0; P<0.001); values above the target range were found in 23.6±16.6% and 49.5±22.8% of the patients, respectively, a difference of 25.9±3.4 percentage points (95% CI, 19.2 to 32.7; P<0.001). The mean glucose level was 154 mg per deciliter (8.5 mmol per liter) in the closed-loop group and 188 mg per deciliter (10.4 mmol per liter) in the control group (P<0.001). There was no significant between-group difference in the duration of hypoglycemia (as defined by a sensor glucose measurement of <54 mg per deciliter; P=0.80) or in the amount of insulin that was delivered (median dose, 44.4 U and 40.2 U, respectively; P=0.50). No episode of severe hypoglycemia or clinically significant hyperglycemia with ketonemia occurred in either trial group. CONCLUSIONS: Among inpatients with type 2 diabetes receiving noncritical care, the use of an automated, closed-loop insulin-delivery system resulted in significantly better glycemic control than conventional subcutaneous insulin therapy, without a higher risk of hypoglycemia. (Funded by Diabetes UK and others; ClinicalTrials.gov number, NCT01774565 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In a randomized controlled trial, people with type 2 diabetes receiving noncritical care had significantly better glycemia with the use of an automated, fully closed-loop insulin delivery system than with conventional subcutaneous insulin therapy, without a higher risk of hypoglycemia (59).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,379
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Discharge planning from hospital to home
Shepperd, S., Lannin, N. A., Clemson, L. M., McCluskey, A., Cameron, I. D., & Barras, S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000313.pub4 · Cited by 936
Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M. (2011) · Diabetes Care · doi:10.2337/dc10-1407 · Cited by 720
Home Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
Self-citationBekiari, E., Kitsios, K., Thabit, H., Tauschmann, M., Athanasiadou, E., Karagiannis, T., Haidich, A.-B., Hovorka, R., & Tsapas, A. (2018) · BMJ · doi:10.1136/bmj.k1310 · Cited by 437
Self-citationSteroid‐induced diabetes: a clinical and molecular approach to understanding and treatment
Hwang, J. L., & Weiss, R. E. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2486 · Cited by 399
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 231
Artificial pancreas systems: experiences from concept to commercialisation
Rodríguez-Sarmiento, D. L., Vargas, F. M. L., & Maira, G. (2022) · Expert Review of Medical Devices · doi:10.1080/17434440.2022.2150546 · Cited by 11
Zhou, D., Li, Z., Shi, G.-Z., & Zhou, J. (2020) · Medicine · doi:10.1097/md.0000000000021728 · Cited by 11
Thabit, H., Rubio, J., Karuppan, M., Mubita, W., Lim, J. Z. M., Thomas, T., Fonseca, I., Fullwood, C., Leelarathna, L., & Schofield, J. D. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15885 · Cited by 10
Self-citationSingle-Hormone Artificial Pancreas Use in Diabetes: Clinical Efficacy and Remaining Challenges
Taleb, N., Tagougui, S., & RABASA-LHORET, R. P. R. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0094 · Cited by 10
All Insulin Pumps Are Not Equivalent: A Bench Test Assessment for Several Basal Rates
Girardot, S., Jacquemier, P., Mousin, F., Rendekeu, C., Hardy, S., & Riveline, J. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0486 · Cited by 10
Phi, N. T. T., Oikonomidi, T., Ravaud, P., & Tran, V.-T. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.2864 · Cited by 9
Diabetesmanagement im Krankenhaus (Update 2019)
Mader, J. K., Aberer, F., Brix, J. M., Föger, B., Hochfellner, D. A., Kietaibl, A.-T., Ludvik, B., Resl, M., Ress-Winkel, C., Stechemesser, L., et al. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1447-z · Cited by 9
Aberer, F., Theiler‐Schwetz, V., Ziko, H., Hausegger, B., Wiederstein‐Grasser, I., Hochfellner, D. A., Eller, P., Tomberger, G., Ellmerer, M., Mader, J. K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63659-4 · Cited by 9
Ishibashi, R., Baba, Y., Kakinuma, K., Takasaki, A., Hiraga, C., Harama, T., Yamamoto, T., Nakamura, S., Koshizaka, M., Maezawa, Y., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00971-2 · Cited by 8
Banholzer, N., Herzig, D., Piazza, C. D., Álvarez‐Martínez, M., Nakas, C. T., Kosinski, C., Feuerriegel, S., Hovorka, R., & Bally, L. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14187 · Cited by 8
Self-citationGlucose Response to Fast- and Long-Acting Insulin in People with Type 2 Diabetes
Engell, S. E., Aradóttir, T. B., Bengtsson, H. L., Ekelund, M., & Jørgensen, J. B. (2021) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2021.10.305 · Cited by 8
Brand, D. A., Peragallo‐Dittko, V., Fazzari, M. J., Islam, S., Jacobson, A. M., & Radin, M. S. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0498 · Cited by 8
The Rational Basis for Personalized Treatment Using Concentration-Guided Dosing
Holford, N. H. G., & Petrić, Z. (2025) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001350 · Cited by 7
Renard, É., Tubiana‐Rufi, N., Chaillous, L., Bonnemaison, É., Hanaire, H. P., Bismuth, É., Joubert, M., Coutant, R., Schaepelynck, P., Beltrand, J., et al. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.04.002 · Cited by 7
Bismuth, É., Joubert, M., Renard, É., Tubiana‐Rufi, N., Chaillous, L., Bonnemaison, É., Hanaire, H. P., Coutant, R., Schaepelynck, P., Beltrand, J., et al. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101637 · Cited by 9
Valk, T. W., & McMorrow, C. (2020) · SAGE Open Medicine · doi:10.1177/2050312120974174 · Cited by 8
Optogenetic therapeutic strategies for diabetes mellitus
Deng, X., Peng, D., Yao, Y., Huang, K., Wang, J., Ma, Z., Fu, J., & Xu, Y. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13557 · Cited by 7
Closed‐loop insulin delivery in end‐of‐life care: a case report
Boughton, C. K., Bally, L., Hartnell, S., Wilinska, M. E., Coll, A. P., Evans, M. L., Stettler, C., & Hovorka, R. (2019) · Diabetic Medicine · doi:10.1111/dme.13974 · Cited by 7
Self-citationKidanemariam, M., Graner, M., Bos, W. J. W., Schroijen, M. A., de Koning, E. J. P., Stiggelbout, A. M., Pieterse, A. H., & Kunneman, M. (2024) · Patient Education and Counseling · doi:10.1016/j.pec.2024.108295 · Cited by 6
Automated Insulin Delivery for Type 1 Diabetes: Present and Future
Akcan, T., Lee, M. Y., Needleman, L., & Lal, R. (2025) · Diabetes Spectrum · doi:10.2337/dsi25-0003 · Cited by 6
Management of Inpatient Hyperglycemia and Diabetes in Older Adults
Davis, G. M., DeCarlo, K., Wallia, A., Umpierrez, G. E., & Pasquel, F. J. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.04.008 · Cited by 8
Inpatient hypoglycaemia; should we should we focus on the guidelines, the targets or our tools?
Yamamoto, J. M., & Murphy, H. R. (2018) · Diabetic Medicine · doi:10.1111/dme.13814 · Cited by 6
Barasch, N., Romig, M. C., Demko, Z. O., Dwyer, C., Dietz, A. S., Rosen, M. A., Griffiths, S., Ravitz, A., Pronovost, P. J., & Sapirstein, A. (2019) · Journal of Patient Safety and Risk Management · doi:10.1177/2516043519893228 · Cited by 6
Initial titration for people with type 1 diabetes using an artificial pancreas
Sejersen, M., Boiroux, D., Engell, S. E., Ritschel, T. K. S., Reenberg, A. T., & Jørgensen, J. B. (2021) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2021.10.303 · Cited by 6
A subcutaneous insulin pharmacokinetic model for insulin Detemir
van Noorden, B., Knopp, J. L., & Chase, J. G. (2019) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2019.06.007 · Cited by 6
Diabetes Technology Use in Special Populations: A Narrative Review of Psychosocial Factors
Hughes, M. S., Aleppo, G., Bally, L., Batista, A. F. M. B., Brown, S. A., Faulds, E. R., Gonder-Frederick, L. A., Isaacs, D. M., Kahkoska, A. R., Ortega, J., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241296853 · Cited by 6
Self-citationAgarwal, S., Demidowich, A. P., Soliman, D., Umpierrez, G. E., & Galindo, R. J. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251364276 · Cited by 5
Molfetta, S. D., Gioia, L. D., Caruso, I., Caporusso, M., Perrini, S., Natalicchio, A., Laviola, L., & Giorgino, F. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70708 · Cited by 5
Closing in on closed-loop systems for type 2 diabetes
Beck, R. W. (2023) · Nature Medicine · doi:10.1038/s41591-022-02127-0 · Cited by 5
Holstein, A., & Bolli, B. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01321-w · Cited by 5
Decision Support Systems and Closed Loop
Nimri, R., Piper, M. M., Pinsker, J. E., & Dassau, E. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.2504 · Cited by 5
Continuous and Intermittent Glucose Monitoring in 2022
Dovč, K., Bode, B. W., & Battelino, T. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.2502 · Cited by 5
Wylie, T. A. F., Shah, C., Burgess, L. C., Robertson, E. J., Dupont, D., Swindell, R., Hovorka, R., Murphy, H. R., & Heller, S. R. (2021) · Diabetic Medicine · doi:10.1111/dme.14647 · Cited by 5
Self-citationEffectiveness and safety of automated insulin delivery in type 2 diabetes: a meta-analysis
Zeng, B., Jia, H., Yang, S., Zheng, J., Yang, Q., & Dou, L. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02014-x · Cited by 4
Müssig, K., Gallwitz, B., Haak, T., Kellerer, M., & Siegel, E. G. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-9700 · Cited by 4
Inpatient Insulin Dosing Calculators
Hansen, J. J., Bacani, G., Juang, P. S., & Kulasa, K. M. (2025) · Diabetes Spectrum · doi:10.2337/dsi25-0002 · Cited by 4
Insulin Pumps for Individuals With Type 2 Diabetes
Brown, S. M., Romeo, G. R., & Toschi, E. (2025) · Diabetes Spectrum · doi:10.2337/dsi25-0005 · Cited by 5
Updates on the Management of Hyperglycemia in Hospitalized Adult Patients
Razavi, L., & Omoregie, C. (2023) · Endocrines · doi:10.3390/endocrines4030037 · Cited by 6
Neue Therapieoptionen mit kontinuierlich gemessenen Glukosedaten – Empfehlungen für die Praxis
Seufert, J., Deiss, D., Gölz, S., Haak, T., Klausmann, G., Kroeger, J., Lobmann, R., Pfeiffer, A. F. H., Schnell, O., Seibold, A., et al. (2019) · Diabetologie und Stoffwechsel · doi:10.1055/a-0978-4537 · Cited by 4
Empfehlungen zur Diabetes-Behandlung mit automatischen Insulin-Dosierungssystemen
Berge, T. V. D., Biester, S., Biester, T., Buchmann, A.-K., Datz, N., Grosser, U., Kapitzke, K., Klusmeier, B., Remus, K., Reschke, F., et al. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1652-9011 · Cited by 4
Three-Day Blood Glucose Control via a Glucose Modulator of Glycopolymersome: Sugar versus Sugar
Xiao, Y., Zhang, J., Wu, T., Chen, S., Huang, Z., & Du, J. (2024) · Chemistry of Materials · doi:10.1021/acs.chemmater.3c03140 · Cited by 4
Müssig, K., Gallwitz, B., Haak, T., Kellerer, M., & Siegel, E. G. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2251-2772 · Cited by 3
Müssig, K., Gallwitz, B., Haak, T., Kellerer, M., & Siegel, E. G. (2025) · Diabetes aktuell · doi:10.1055/a-2500-1766 · Cited by 3
Les médicaments anti-diabétiques : ce que le médecin anesthésiste réanimateur doit savoir
Joubert, M. (2023) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2023.04.001 · Cited by 3
Müssig, K., Gallwitz, B., Haak, T., Kellerer, M., & Siegel, E. G. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2312-1160 · Cited by 3
Frequency of thrombolytic targets in stroke patients presenting in an extended time window
Leigh, R. J., Heidari, P., Blayney, S., Butler, J., Hitomi, E., & Luby, M. L. (2020) · Brain Circulation · doi:10.4103/bc.bc_12_20 · Cited by 3
La variabilité glycémique : un facteur de risque singulier à conjuguer au pluriel
Monnier, L., Colette, C., Bonnet, F., & Owens, D. R. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.11.003 · Cited by 3
Glucose Control in the Intensive Care Unit
Gunst, J., & den Berghe, G. V. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_42 · Cited by 3
Glycaemic management in patients with diabetes in hospital
Sharma, S., Rajendran, R., & Rayman, G. A. (2018) · Medicine · doi:10.1016/j.mpmed.2018.10.008 · Cited by 3
New technical approach to the diabetes therapy
Dovč, K., & Battelino, T. (2020) · Minerva Pediatrics · doi:10.23736/s0026-4946.20.05865-x · Cited by 3
Inpatient Use of Automated Insulin Delivery Systems
Chadalawada, L., Parab, R., Feeley, J. M., Hughes, M. S., Pasquel, F. J., & Davis, G. M. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251412442 · Cited by 3
Recent advances and perspectives in novel insulin release systems
Barkhordari, S., Samandari, S. S., Abdouss, M., & Pourmadadi, M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106500 · Cited by 1
Bombaci, B., Passanisi, S., Torre, A., Sbilordo, S., Ini’, E., Papa, M., Valenzise, M., Lombardo, F., & Salzano, G. (2025) · Diabetology · doi:10.3390/diabetology6090090 · Cited by 6
Paoli, L. L., Rizzi, A., Tartaglione, L., D'Amore, D., Vinti, L., Barberio, A., Sciaraffia, G., Viti, L., Leo, M. A. S. D., Pontecorvi, A., et al. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70154 · Cited by 2
Automated Insulin Delivery Systems in Hospitals: A Systematic Review with Meta-Analysis
Olsen, M. T., Liarakos, A. L., Wilmot, E. G., Dhatariya, K., Mustafa, O. G., Thabit, H., Kristensen, P. L., Andersen, T. H., Klopf, P., Nørgaard, K., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261457746 · Cited by 2
Self-citationMcGill, J. B., Donihi, A. C., Aktürk, H. K., Freeby, M., Gupta, A., Horton, W. B., Jadoon, M. N., Lathief, S., Miracle-López, S., Tan, C., et al. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.06.011 · Cited by 3
Closed-loop management of inpatient hyperglycaemia
Boughton, C. K., & Hovorka, R. (2019) · British Journal of Hospital Medicine · doi:10.12968/hmed.2019.80.11.665 · Cited by 2
Self-citationForlenza, G. P., Tabatabai, I., & Lewis, D. M. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0073 · Cited by 2
Early Stages of Automated Insulin Delivery
Zisser, H., Hovorka, R., Basu, A., Battelino, T., Boughton, C. K., Breton, M. D., Buckingham, B. A., Brown, S. A., Cherñavvsky, D. R., Dassau, E., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.18802.hz · Cited by 3
Self-citationContinuous glucose monitoring: review of promising technologies
Klimek, M., & Tulwin, T. (2019) · MATEC Web of Conferences · doi:10.1051/matecconf/201925202012 · Cited by 2
Open Source Medical Device Safety: Loop Artificial Pancreas Case Report
Dorin, M., Mortensen, H., & Montenegro, S. (2020) · IEEE Symposium on Product Compliance Engineering (ISPCE) · doi:10.1109/spce50045.2020.9296152 · Cited by 2
Bremer, A. A., & Arreaza-Rubín, G. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818823770 · Cited by 2
Diabetes and Technology in the Covid-19 Pandemic Crisis
Spanakis, E. K. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820929385 · Cited by 2
Monnier, L., & Colette, C. (2022) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.12.006 · Cited by 2
The Need for Diabetes Advance Directives to Support the Care of People With Diabetes
Lewis, D. M. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221076558 · Cited by 2
Pains and needs of patients with type 2 diabetes as targets for novel technologies
Gruchała, A., Cypryk, K., Schliess, F., Bobeff, K. Ł., Heise, T., Gurdała, M., Szadkowska, A., & Mianowska, B. (2020) · Clinical Diabetology · doi:10.5603/dk.2020.0052 · Cited by 1
Assistive technology for diabetes management: a toolkit
Barmanray, R., Kyi, M., & Fourlanos, S. (2022) · British Journal of Healthcare Management · doi:10.12968/bjhc.2022.0057 · Cited by 1
Artificial Intelligence for Diabetes in the Hospital
Sly, B. P., Shrapnel, S., & Sullivan, C. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13244-5.00021-3 · Cited by 1
Müssig, K., Gallwitz, B., Haak, T., Kellerer, M., & Siegel, E. G. (2025) · Die Diabetologie · doi:10.1007/s11428-024-01276-9 · Cited by 1
Müssig, K., Gallwitz, B., Haak, T., Kellerer, M., & Siegel, E. G. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2490-5208 · Cited by 1
Flabouris, K., Pearson, O. R., Morey, K., Edwards, S., Jesudason, D. R., & Marathe, C. S. (2026) · Diabetic Medicine · doi:10.1111/dme.70400 · Cited by 1
Wo steht das künstliche Pankreas in der Diabetestherapie?
Dimou, M., Laimer, M. W., Stettler, C., & Bally, L. (2019) · Der Internist · doi:10.1007/s00108-019-00713-y · Cited by 1
Self-citationGlycaemic control in critical care: Can flash glucose monitoring help?
Moncrieff, J., Jayagopal, V., & Yates, D. (2021) · Journal of the Intensive Care Society · doi:10.1177/17511437211043356 · Cited by 1
Management of the Inpatient with Diabetes Mellitus
Rayman, G. A. (2022) · doi:10.1093/med/9780198870197.003.0266 · Cited by 1
Luca, M. D. (2022) · The Journal of AMD · doi:10.36171/jamd22.25.2.1 · Cited by 1
Liu, W., Cai, D., Zhang, R., Zhang, X., Cai, X., Tao, L., Han, X., Luo, Y., Li, M., Wu, W., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae143 · Cited by 1
Yang, W., Lü, J., Si, S.-C., Wang, W., Li, J., Ma, Y.-X., Zhao, H., & Liu, J. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i4.103002 · Cited by 1
Endocrinology: What You May Have Missed in 2024
Aman, M., Jeevananthan, A., Martinez-Cruz, M., Namasingh, N., & Batch, B. C. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-00990 · Cited by 1
Early Stages of Automated Insulin Delivery
Zisser, H., Hovorka, R., Basu, A., Battelino, T., Boughton, C. K., Breton, M. D., Buckingham, B. A., Brown, S. A., Cherñavvsky, D. R., Dassau, E., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251335685 · Cited by 1
Self-citationAutomated Insulin Delivery Systems for People with Type 2 Diabetes
Arentsen, M. G., Boiroux, D., Mohebbi, A., Aradóttir, T. B., Bengtsson, H. L., & Jørgensen, J. B. (2025) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2025.06.002 · Cited by 1
Williams, M. E. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.003 · Cited by 1
Masys, J., Peng, C., Ahn, A. C., & Masys, A. J. (2021) · Advanced sciences and technologies for security applications · doi:10.1007/978-3-030-71998-2_13 · Cited by 1
Mesterséges hasnyálmirigy – A cukorbetegség automatikus kezelése mérnöki megközelítéssel
Kovács, L., Eigner, G., Czako, B. G., Siket, M., Almássy, Z., Kocsis, G., & Barkai, L. (2019) · Diabetologia Hungarica · doi:10.24121/dh.2019.21 · Cited by 1
Closed-loop management of inpatient hyperglycemia
Boughton, C. K., Bally, L., & Hovorka, R. (2019) · Aging · doi:10.18632/aging.102144 · Cited by 1
Self-citationIn‐Hospital Treatment and Surgery in People with Diabetes
Dhatariya, K., Newland‐Jones, P., & Patel, M. A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch39 · Cited by 3
Averaged glycaemic variability or by average: More than a simple question of wording
Monnier, L., Colette, C., & Bonnet, F. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101550 · Cited by 1
Quel scénario pour le déploiement de l'insulinothérapie automatisée en boucle fermée ?
Benhamou, P., Franc, S., Hanaire, H. P., Penfornis, A., & Charpentier, G. (2018) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30176-7
Glycaemic control on nutritional support: finding stability in unstable times
Gillard, P., Charleer, S., & Mathieu, C. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30094-4
Measures of Glycemic Control and The Case for More Frequent Testing of HbA1c
Burd, J. F. (2019) · Nursing & Primary Care · doi:10.33425/2639-9474.1102
Latres, E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814831-0.00036-1
Hesse, M., Thylstrup, B., Karsberg, S., Pedersen, M. M., & Pedersen, M. U. (2021) · Journal of Dual Diagnosis · doi:10.1080/15504263.2021.1942379
Alley Baggett - Attrice straniera foto immagine
Wallpapers (2003)
“Closed Loop” Insulin Delivery
Hovorka, R., & Boughton, C. K. (2022) · doi:10.1093/med/9780198870197.003.0264
Self-citationEstrategias de control avanzadas para páncreas artificial
Fushimi, E. (2021) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/133534
Empfehlungen zur Diabetes-Behandlung mit automatischen Insulin-Dosierungssystemen
Berge, T. V. D., Biester, S., Biester, T., Buchmann, A.-K., Datz, N., Grosser, U., Kapitzke, K., Klusmeier, B., Remus, K., Reschke, F., et al. (2022) · Diabetes aktuell · doi:10.1055/a-1851-2883
Inpatient Precision Medicine for Diabetes
Davis, G. M., Umpierrez, G. E., & Pasquel, F. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_9
Herzig, D., Suhner, S., Roos, J., Schürch, D., Cecchini, L., Nakas, C. T., Weiss, S., Kadner, A., Kocher, G. J., Guensch, D. P., et al. (2022) · doi:10.2337/figshare.20090087
Self-citationHerzig, D., Suhner, S., Roos, J., Schürch, D., Cecchini, L., Nakas, C. T., Weiss, S., Kadner, A., Kocher, G. J., Guensch, D. P., et al. (2022) · doi:10.2337/figshare.20090087.v1
Self-citation
Metadata
- Authors
- Bally, L., Thabit, H., Hartnell, S., Andereggen, E., Ruan, Y., Wilinska, M. E., Evans, M. L., Wertli, M. M., Coll, A. P., Stettler, C., & Hovorka, R.
- Affiliations
- University of Bern (CH)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-08-09
- Volume
- 379
- Issue
- 6
- Pages
- 547-556
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2810166631
- Cited by
- 232
- References
- 27
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 29 · 2023: 24 · 2022: 21 · 2021: 22 · 2020: 37 · 2019: 41 · 2018: 9
- FWCI
- 21.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Apollo
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Diabetes UK (14/0004878)
- European Foundation for the Study of Diabetes
- Universität Bern
- Swiss Diabetes Foundation
- University Hospital Bern
- National Institute for Health Research Cambridge Biomedical Research Centre and Wellcome Strategic Award (100574/Z/12/Z)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P1BEP3_165297)
- JDRF
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- artificial pancreas, type 2 diabetes, glycemic control, subcutaneous insulin therapy, continuous glucose monitoring, hypoglycemia, hyperglycemia, hospitalization, glycemic targets, insulin dose, general ward patients
- MeSH terms
- Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Hospitalization, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Middle Aged, Pancreas, Artificial, Infusions, Subcutaneous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
